Combined magnetic resonance and fluorescence imaging of the living mouse brain reveals glioma response to chemotherapy

Bindal, 1994, Prognostic significance of proteolytic enzymes in human brain tumors, J. Neuro-oncol., 22, 101, 10.1007/BF01052886 Blum, 2005, Dynamic imaging of protease activity with fluorescently quenched activity-based probes, Nat. Chem. Biol., 1, 203, 10.1038/nchembio728 Brat, 2004, Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population, Cancer Res., 64, 920, 10.1158/0008-5472.CAN-03-2073 Bremer, 2003, Optical-based molecular imaging: contrast agents and potential medical applications, Eur. Radiol., 13, 231, 10.1007/s00330-002-1610-0 Graves, 2005, Validation of in vivo fluorochrome concentrations measured using fluorescence molecular tomography, J. Biomed. Opt., 10, 44019, 10.1117/1.1993427 Hintersteiner, 2005, In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe, Nat. Biotechnol., 23, 577, 10.1038/nbt1085 Izmailova, 2007, Use of molecular imaging to quantify response to IKK-2 inhibitor treatment in murine arthritis, Arthritis Rheum., 56, 117, 10.1002/art.22303 Jaffer, 2006, Molecular and cellular imaging of atherosclerosis: emerging applications, J. Am. Coll. Cardiol., 47, 1328, 10.1016/j.jacc.2006.01.029 Jiang, 2004, Tumor imaging by means of proteolytic activation of cell-penetrating peptides, Proc. Natl. Acad. Sci. U. S. A., 101, 17867, 10.1073/pnas.0408191101 Kak, 1988 Kelloff, 2005, The progress and promise of molecular imaging probes in oncologic drug development, Clin. Cancer Res., 11, 7967, 10.1158/1078-0432.CCR-05-1302 Koblinski, 2000, Unraveling the role of proteases in cancer, Clin. Chim. Acta, 291, 113, 10.1016/S0009-8981(99)00224-7 Lardinois, 2003, Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography, N. Engl. J. Med., 348, 2500, 10.1056/NEJMoa022136 Moffat, 2005, Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response, Proc. Natl. Acad. Sci. U. S. A., 102, 5524, 10.1073/pnas.0501532102 Monje, 2003, Inflammatory blockade restores adult hippocampal neurogenesis, Science, 302, 1760, 10.1126/science.1088417 Montet, 2005, Tomographic fluorescence mapping of tumor targets, Cancer Res., 65, 6330, 10.1158/0008-5472.CAN-05-0382 Nahrendorf, 2007, Dual channel optical tomographic imaging of leukocyte recruitment and protease activity in the healing myocardial infarct, Circ. Res., 100, 1218, 10.1161/01.RES.0000265064.46075.31 Nesterov, 2005, In vivo optical imaging of amyloid aggregates in brain: design of fluorescent markers, Angew. Chem., Int. Ed. Engl., 44, 5452, 10.1002/anie.200500845 Ntziachristos, 2000, Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement, Proc. Natl. Acad. Sci. U. S. A., 97, 2767, 10.1073/pnas.040570597 Ntziachristos, 2002, In vivo tomographic imaging of near-infrared fluorescent probes, Mol. Imaging, 1, 82, 10.1162/153535002320162732 Ntziachristos, 2002, Would near-infrared fluorescence signals propagate through large human organs for clinical studies?, Opt. Lett., 27, 333, 10.1364/OL.27.000333 Ntziachristos, 2002, Fluorescence molecular tomography resolves protease activity in vivo, Nat. Med., 8, 757, 10.1038/nm729 Ntziachristos, 2003, Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging, Eur. Radiol., 13, 195, 10.1007/s00330-002-1524-x Ntziachristos, 2004, Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate, Proc. Natl. Acad. Sci. U. S. A., 101, 12294, 10.1073/pnas.0401137101 Ntziachristos, 2005, Looking and listening to light: the evolution of whole-body photonic imaging, Nat. Biotechnol., 23, 313, 10.1038/nbt1074 Otsuka, 2007, FDG-PET/CT for cancer management, J. Med. Investig., 54, 195, 10.2152/jmi.54.195 Schiff, 2007, Temozolomide and radiation in low-grade and anaplastic gliomas: temoradiation, Cancer Investig., 25, 776, 10.1080/07357900701509403 Shcherbo, 2007, Bright far-red fluorescent protein for whole-body imaging, Nat. Methods, 4, 741, 10.1038/nmeth1083 Sloane, 1996, Suicidal tumor proteases, Nat. Biotechnol., 14, 826, 10.1038/nbt0796-826b Trehin, 2006, Fluorescent nanoparticle uptake for brain tumor visualization, Neoplasia, 8, 302, 10.1593/neo.05751 Vasiljeva, 2006, Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer, Cancer Res., 66, 5242, 10.1158/0008-5472.CAN-05-4463 Veit-Haibach, 2006, Diagnostic accuracy of colorectal cancer staging with whole-body PET/CT colonography, Jama, 296, 2590, 10.1001/jama.296.21.2590 von Wallbrunn, 2007, In vivo imaging of integrin alpha v beta 3 expression using fluorescence-mediated tomography, Eur. J. Nucl. Med. Mol. Imaging, 34, 745, 10.1007/s00259-006-0269-1 Weber, 2008, Technology insight: advances in molecular imaging and an appraisal of PET/CT scanning, Nat. Clin. Pract. Oncol., 5, 160, 10.1038/ncponc1041 Weissleder, 2003, Shedding light onto live molecular targets, Nat. Med., 9, 123, 10.1038/nm0103-123 Weissleder, 1999, In vivo imaging of tumors with protease-activated near-infrared fluorescent probes, Nat. Biotechnol., 17, 375, 10.1038/7933 Zacharakis, 2005, Volumetric tomography of fluorescent proteins through small animals in vivo, Proc. Natl. Acad. Sci. U. S. A., 102, 18252, 10.1073/pnas.0504628102